181 related articles for article (PubMed ID: 28045974)
1. Neonatal Immunization with a Single IL-4/Antigen Dose Induces Increased Antibody Responses after Challenge Infection with Equine Herpesvirus Type 1 (EHV-1) at Weanling Age.
Wagner B; Perkins G; Babasyan S; Freer H; Keggan A; Goodman LB; Glaser A; Torsteinsdóttir S; Svansson V; Björnsdóttir S
PLoS One; 2017; 12(1):e0169072. PubMed ID: 28045974
[TBL] [Abstract][Full Text] [Related]
2. Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccine.
Wagner B; Goodman LB; Babasyan S; Freer H; Torsteinsdóttir S; Svansson V; Björnsdóttir S; Perkins GA
Vaccine; 2015 Oct; 33(42):5588-5597. PubMed ID: 26384446
[TBL] [Abstract][Full Text] [Related]
3. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
4. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
[TBL] [Abstract][Full Text] [Related]
5. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
[TBL] [Abstract][Full Text] [Related]
6. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
[TBL] [Abstract][Full Text] [Related]
7. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R
Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066
[TBL] [Abstract][Full Text] [Related]
8. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection.
Patel JR; Didlick S; Bateman H
Equine Vet J; 2004 Jul; 36(5):447-51. PubMed ID: 15253088
[TBL] [Abstract][Full Text] [Related]
10. The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens.
Breathnach CC; Yeargan MR; Sheoran AS; Allen GP
Equine Vet J; 2001 Nov; 33(7):651-7. PubMed ID: 11770985
[TBL] [Abstract][Full Text] [Related]
11. Immunological correlates of vaccination and infection for equine herpesvirus 1.
Goodman LB; Wimer C; Dubovi EJ; Gold C; Wagner B
Clin Vaccine Immunol; 2012 Feb; 19(2):235-41. PubMed ID: 22205656
[TBL] [Abstract][Full Text] [Related]
12. Duration of immunity induced by an adjuvanted and inactivated equine influenza, tetanus and equine herpesvirus 1 and 4 combination vaccine.
Heldens JG; Kersten AJ; Weststrate MW; van den Hoven R
Vet Q; 2001 Nov; 23(4):210-7. PubMed ID: 11765243
[TBL] [Abstract][Full Text] [Related]
13. Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines.
Bresgen C; Lämmer M; Wagner B; Osterrieder N; Damiani AM
Vet Microbiol; 2012 Nov; 160(1-2):9-16. PubMed ID: 22633483
[TBL] [Abstract][Full Text] [Related]
14. Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody.
Ruitenberg KM; Love DN; Gilkerson JR; Wellington JE; Whalley JM
Vet Microbiol; 2000 Sep; 76(2):117-27. PubMed ID: 10946142
[TBL] [Abstract][Full Text] [Related]
15. Concurrent vaccination against equine influenza and equine herpesvirus - a practical approach.
Gildea S; Sanchez Higgins MJ; Johnson G; Walsh C; Cullinane A
Influenza Other Respir Viruses; 2016 Sep; 10(5):433-7. PubMed ID: 27169603
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of foals with a modified live, equid herpesvirus-1 gM deletion mutant (RacHΔgM) confers partial protection against infection.
Kydd JH; Hannant D; Robinson RS; Bryant N; Osterrieder N
Vaccine; 2020 Jan; 38(2):388-398. PubMed ID: 31629571
[TBL] [Abstract][Full Text] [Related]
17. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the molecular detection of vaccine-derived equine herpesvirus type 1 in blood and nasal secretions from horses following intramuscular vaccination.
Pusterla N; Chaney KP; Maes R; Wise AG; Holland R; Schott HC
J Vet Diagn Invest; 2007 May; 19(3):290-3. PubMed ID: 17459860
[TBL] [Abstract][Full Text] [Related]
19. Intranasal IgG4/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia.
Perkins G; Babasyan S; Stout AE; Freer H; Rollins A; Wimer CL; Wagner B
Virology; 2019 May; 531():219-232. PubMed ID: 30928700
[TBL] [Abstract][Full Text] [Related]
20. Comparison of protective efficacies between intranasal and intramuscular vaccination of horses with a modified live equine herpesvirus type-1 vaccine.
Bannai H; Nemoto M; Tsujimura K; Yamanaka T; Kokado H; Kondo T; Matsumura T
Vet Microbiol; 2018 Aug; 222():18-24. PubMed ID: 30080668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
